Health Care & Life Sciences » Pharmaceuticals | La Jolla Pharmaceutical Co.

La Jolla Pharmaceutical Co. | Ownership

Companies that own La Jolla Pharmaceutical Co.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Perceptive Advisors LLC
4,313,611
16.45%
0
2.25%
06/30/2018
Tang Capital Management LLC
4,138,893
15.78%
0
12.9%
06/30/2018
Fidelity Management & Research Co.
3,644,134
13.9%
54,736
0.01%
06/30/2018
Jennison Associates LLC
3,188,533
12.16%
51,471
0.06%
06/30/2018
Scopia Capital Management LP
2,583,170
9.85%
2,005,025
1.02%
06/30/2018
SSgA Funds Management, Inc.
1,520,888
5.8%
40,600
0%
06/30/2018
Broadfin Capital LLC
1,494,520
5.7%
-162,200
4.74%
06/30/2018
RTW Investments LP
1,345,881
5.13%
223,341
1.78%
06/30/2018
BlackRock Fund Advisors
1,329,731
5.07%
250,957
0%
06/30/2018
Sectoral Asset Management, Inc.
1,313,105
5.01%
184,886
3%
06/30/2018

About La Jolla Pharmaceutical

View Profile
Address
4550 Towne Centre Court
San Diego California 92121
United States
Employees -
Website http://www.lajollapharmaceutical.com
Updated 07/08/2019
La Jolla Pharmaceutical Co. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. Its products includes LJPC-501, LJPC-401, LJPC-30Sa and LJPC-30Sb. LJPC-501 is the proprietary formulation for angiotensin II.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.